Aligos Therapeutics Inc. (ALGS) Misses Q4 EPS by 1308c
Tweet
Share
E-mailGet Alerts ALGS Hot Sheet
Join SI Premium – FREE
Aligos Therapeutics Inc. (NASDAQ: ALGS) reported Q4 EPS of ($13.08).
For earnings history and earnings-related data on Aligos Therapeutics Inc. (ALGS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Science Applications (SAIC) PT Raised to $123 at UBS
- TETRA Technologies Inc. (TTI) PT Lowered to $10 at Northland
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
